FRANKLIN TEMPLETON ETF TR - GENOMIC ADV ETF (HELX)

Historical Portfolio Holders from Q1 2020 to Q3 2024

All holders as of September 30, 2024
Q3 2024
Type / Class
Equity / GENOMIC ADV ETF
Shares, excl. options Q3 2024
47.7K
Holdings value Q3 2024
$1.55M
Value change Q3 2024
-$963K
Grand Portfolio weight change Q3 2024
0%
Number of holders
5
Number of buys Q3 2024
3
Number of sells Q3 2024
-4
Average buys Q3 2024 %
+0%
Average sells Q3 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 47.7K $1.55M -$963K $32.41 5
2024 Q2 78.1K $2.48M -$568K $31.68 7
2024 Q1 95K $3.11M -$1.5M $32.76 10
2023 Q4 141K $4.29M +$3.13M $30.47 9
2023 Q3 38.7K $1.1M -$1.32M $28.34 7
2023 Q2 82.3K $2.49M -$37.7K $30.23 7
2023 Q1 38.8K $1.18M -$122K $30.38 6
2022 Q4 42.8K $1.29M +$61.9K $30.13 9
2022 Q3 40.7K $1.21M +$315K $29.63 9
2022 Q2 30.1K $964K -$80.1K $32.02 8
2022 Q1 31.5K $1.16M -$4.71M $36.95 8
2021 Q4 155K $7.53M -$6.28M $48.42 11
2021 Q3 274K $14.3M +$10.2M $52.30 10
2021 Q2 79.6K $4.12M -$98.5K $51.79 9
2021 Q1 81.5K $3.53M +$1.39M $43.35 8
2020 Q4 43.3K $1.92M +$761K $44.29 5
2020 Q3 28.2K $991K -$1.29M $35.10 5
2020 Q2 65K $2.23M -$343K $34.29 1
2020 Q1 75K $1.68M +$1.68M $22.37 1